Iranian researchers have discovered that the side effects of the drug Mitoxantrone could be reduced when the chemotherapeutic agent is infused with liposomic nanocarriers.
Iranian scientists have successfully reduced the side effects of a cancer drug by infusing it with nanotechnology.
Researchers at the Tabriz University of Medical Sciences discovered that the side effects of the drug Mitoxantrone could be reduced when the chemotherapeutic agent is infused with liposomic nanocarriers, which are created with cholesterol derivatives, IRNA reported on Tuesday.
Mitoxantrone is a cancer drug that disrupts DNA synthesis and DNA repair in both healthy cells and cancer cells, and is used to treat certain types of cancer such as metastatic breast cancer, acute myeloid leukemia, and non-Hodgkin’s lymphoma.
The produced “nanoliposomes,” apart from being stable to pH changes in blood plasma, have proven to be more poisonous to cancer cells than to normal cells, which would reduce the required dosage and side effects, said head of the research team Dr. Saeed Qanbarzadeh.
The most common side effects of Mitoxantrone, which hinder its wider spread use, are nausea, vomiting, hair loss, heart damage, and immunosuppression.
Pro-Palestine students at campuses across the United Kingdom have set up encampments demanding that their…
Tel Aviv has threatened that it will retaliate against the Palestinian Authority (PA) if the…
Palestinian human rights organisations have reported that there is no information available about 1,000 workers…
Western nations are lagging behind Russia in their endeavours to step up defense production, leading…
Kremlin spokesman Dmitry Peskov has rejected claims by Washington that Moscow has engaged in chemical…
A fire incident early on Thursday ravaged at least 150 residential and commercial units in…